Nexgel Inc
NASDAQ:NXGL

Watchlist Manager
Nexgel Inc Logo
Nexgel Inc
NASDAQ:NXGL
Watchlist
Price: 4.73 USD 2.38% Market Closed
Market Cap: 35.6m USD
Have any thoughts about
Nexgel Inc?
Write Note

Net Margin
Nexgel Inc

-52.5%
Current
-180%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-52.5%
=
Net Income
-3.5m
/
Revenue
6.7m

Net Margin Across Competitors

Country US
Market Cap 35.6m USD
Net Margin
-52%
Country JP
Market Cap 6.8T JPY
Net Margin
24%
Country CH
Market Cap 37.6B CHF
Net Margin
12%
Country DK
Market Cap 179.6B DKK
Net Margin
19%
Country US
Market Cap 15.8B USD
Net Margin
11%
Country CN
Market Cap 52B CNY
Net Margin
42%
Country CA
Market Cap 6.3B USD
Net Margin
-8%
Country KR
Market Cap 9.1T KRW
Net Margin
-358%
Country US
Market Cap 6.2B USD
Net Margin
29%
Country US
Market Cap 5.7B USD
Net Margin
9%
Country UK
Market Cap 4.5B GBP
Net Margin
7%
No Stocks Found

Nexgel Inc
Glance View

Market Cap
35.6m USD
Industry
Health Care

NexGel, Inc. engages in the manufacture of polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company is headquartered in Langhorne, Pennsylvania. The company went IPO on 2021-12-22. The firm is engaged in the manufactures of high-water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery and cosmetics. The firm specializes in custom gels by capitalizing on manufacturing technologies. Its products are manufactured by using proprietary and non-proprietary mixing, coating and cross-linking technologies. The company operates as a contract manufacturer of aqueous polymer hydrogels. The company delivers medication through hydrogel patches. Its Hydrogel patches are used for transdermal applications, such as hormone replacement therapy and contraception, treatment of acne, shingles, diabetes, motion sickness, treatment of angina with nitroglycerin and treatment of smoking addiction.

NXGL Intrinsic Value
7.73 USD
Undervaluation 39%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-52.5%
=
Net Income
-3.5m
/
Revenue
6.7m
What is the Net Margin of Nexgel Inc?

Based on Nexgel Inc's most recent financial statements, the company has Net Margin of -52.5%.